GEC/ESTRO-EAU recommendations on temporary brachytherapy using stepping sources for localised prostate cancer

Radiotherapy and Oncology

Volumn 74, Issue 2, 2005, Pages 137-148

  Kovács, György ^a   Pötter, Richard ^b   Loch, Tillmann ^c   Hammer, Josef ^d   Kolkman Deurloo, Inger Karine ^e   De La Rosette, Jean J M C H ^f   Bertermann, Hagen ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY OF VIENNA   (Austria)

^c SAARLAND UNIVERSITY   (Germany)

^d Krankenhaus der Barmherzigen Schwestern Wien Betriebsgesellschaft   (Austria)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Afterloading; HDR brachytherapy; Prostate cancer; Recommendations; Stepping source technology; Transrectal ultrasound

Indexed keywords

IRIDIUM 192;

ARTICLE; BEAM THERAPY; BONE METASTASIS; BONE SCINTISCANNING; BRACHYTHERAPY; CANCER HORMONE THERAPY; CANCER LOCALIZATION; CANCER PALLIATIVE THERAPY; CANCER STAGING; CATHETERIZATION; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; CYSTITIS; DISEASE SEVERITY; DYSURIA; FOLLOW UP; LYMPH NODE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERINEUM INJURY; POTENCY DISORDER; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROCTITIS; PROGNOSIS; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIATION PROTECTION; SALVAGE THERAPY; TRANSRECTAL ULTRASONOGRAPHY; TREATMENT CONTRAINDICATION; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR BIOPSY; URETHRA STRICTURE; URINE INCONTINENCE; URINE RETENTION; URINE VOLUME; URODYNAMICS;

EID: 14744282491     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2004.09.004     Document Type: Article

References (74)

1. American Society for Therapeutic Radiology and Oncology Consensus Panel Consensus statement: guidelines for PSA following radiation therapy Int J Radiat Oncol Biol Phys 37 1997 1035 1041
2. D. Ash, A. Flynn, and J. Battermann ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer Radiother Oncol 57 2000 315 321
3. J.J. Battermannn Feasibility of permanent implants for prostate cancer after previous radiotherapy in the true pelvis Radiother Oncol 57 2000 297 300
4. H. Bertermann, and F. Brix Ultrasonically guided interstitial high dose rate brachytherapy with Ir-192: technique and preliminary results in locally confined prostate cancer A.A. Martinez C.F. Orton R.F. Mould Brachytherapy HDR and LDR: remote afterloading state of the art 1990 Nucletron International BV Leersum, The Netherlands 281 303
5. H. Bertermann Transrektale Sonographie von Prostata und Samenblasen. T-Klassifikation 1997 Ecomed Landsberg p. 25-59
6. J.C. Blasko, P.D. Grimm, and H. Ragde Brachytherapy and organ preservation in the management of carcinoma of the prostate Semin Radiat Oncol 3 1993 240 249
7. J.C. Blasko, H. Ragde, and D. Schumacher Transperineal percutaneous iodine 125 implantations for prostatic carcinoma using transrectal ultrasound and template guidance Endocurie Hypertherm Oncol 3 1987 131 139
8. M. Bolla, D. Gonsales, and P. Warde Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin N Engl J Med 337 1997 295 300
9. G. Borghede, H. Hedelin, and S. Holmäng Combined treatment with temporary short-term high dose rate iridium-192 brachytherapy and external beam radiotherapy for irradiation of localized prostatic carcinoma Radiother Oncol 44 1997 237 244
10. G. Borghede, H. Hedelin, S. Holmäng, K.A. Johansson, G. Sernbo, and C. Mercke Irradiation of localized prostatic carcinoma with a combination of high dose rate iridium-192 brachytherapy and external beam radiotherapy with three target definitions and dose levels inside the prostate gland Radiother Oncol 44 1997 245 250
11. D.J. Brenner, A.A. Martinez, and G.K. Edmundson Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue Int J Radiat Oncol Biol Phys 52 2002 6 13
12. G. Bruggmoser, N. Nanko, M. Hempel, R. Heitz, and M. Wannenmacher Equipment for rapid and reliable perineal implantation of I-125 seeds in prostatic cancer with reduced radiation exposure Strahlenther Onkol 163 1987 593 594
13. J.A. Cadeddu, A.W. Partin, T.L. De Wese, and P.C. Walsh Long term results of radiation therapy for prostate cancer recurrence following radical prostatectomy J Urol 159 1998 173 178
14. G.W. Chodak, V. Wald, and E. Parmer Comparison of digital examination and transrectal ultrasonography for the diagnosis of prostate cancer J Urol 135 1986 951 954
15. M.S. Cookson, N.E. Fleshner, and S.M. Soloway Correlation between Gleason score of needle biopsy and radical prostatectomy specimen: accuracy and clinical implications J Urol 157 1997 559 562
16. J.W. Davis, P. Kolm, and G.L. Wright The durability of external beam radiation therapy for prostate cancer: can it be identified? J Urol 162 1999 758 761
17. J.J.M.C. De la Rosette, and R.G. Aarnink New developments in ultrasonography for the detection of prostate cancer J Endourol 15 2001 93 104
18. D.J. Demanes, R.R. Rodrigues, and G.A. Altieri High dose rate prostate brachytherapy: the California endocurietherapy (CET) method Radiother Oncol 57 2000 289 296
19. Devlin PM, Brus CR, Kazakin J, et al. First national survey on the use of high dose rate afterloading brachytherapy for carcinoma of the prostate. Proceedings of the 10th international brachytherapy conference. Madrid, Spain; 11-14 November, 2000, p. 60. [Abstract #30].
20. S. Dinges, S. Deger, and S. Koswig High dose rate interstitial brachytherapy combined with external beam irradiation for localized prostate cancer - a prospective study Radiother Oncol 48 1998 197 203
21. W.D. D'Sousa, and H.D. Thames Is the alpha/beta ratio for prostate cancer low? Int J Radiat Oncol Biol Phys 51 2001 1 3
22. G.K. Edmundson, R.T. Di Yan, and A.A. Martinez Intraoperative optimisation of needle placement and dwell times for conformal prostate brachytherapy Int J Radiat Oncol Biol Phys 33 1995 1257 1263
23. R.M. Galalae, G. Kovács, and J. Schultze Long term outcome after elective irradiation on the pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancer Int J Radiat Oncol Biol Phys 52 2002 81 90
24. R. Galalae, A.A. Martinez, C. Mitchell, G.S. Gustafson, and G. Kovacs No benefit at 5 years from a brief course of neoadjuvant androgen deprivation for prostate cancer patients treated with a conformal high dose rate brachytherapy boost (Abstract) Int J Radiat Oncol Biol Phys 51 2001 319
25. R. Galalae, G. Kovács, and T. Loch Anatomy-related and transrectal sonography-guided interstitial high-dose-rate brachytherapy combined with elective irradiation of the pelvic lymphatics for localized prostate cancer: the Kiel experience T. Wiegel R. Heicapell K. Miller W. Hinkelbein Controversies in uro-oncology. Front Radiat Ther Oncol vol. 36 2002 Karger Basel 183 190
26. R. Galalae, B. Riemer, and P. Rzehak Is health related quality of life status a new prognostic factor for survival in men with localized prostate cancer? Measurement following high dose rate brachytherapy and teletherapy using a prostate specific instrument (Abstract) Radiother Oncol 55 2000 47
27. J. Hammer Iodine-125 seed implantation in the treatment of prostatic carcinoma Strahlenther Onkol 167 1991 63 81
28. W. Hinkelbein Adjuvant or therapeutic androgen suppression in locoregional advanced prostatic carcinoma (RTOG 85-31) [Article in German] Strahlenther Onkol 174 1998 385 386
29. P.J. Hoskin High dose rate brachytherapy boost treatment in radical radiotherapy for prostate cancer Radiother Oncol 57 2000 285 288
30. J.I. Hsu, B. Pickett, K. Shinohara, R. Krieg, M. Roach III, and T. Phillips Normal tissue dosimetric comparison between HDR prostate implant boost and conformal external beam radiotherapy boost: potential for dose escalation Int J Radiat Oncol Biol Phys 46 2000 851 858
31. K. Hu, and K. Wallner Rectal and urinary morbidity in patients undergoing prostate I-125 implant (Abstract) Int J Radiat Oncol Biol Phys 39 1997 292
32. ICRU Report 58. Dose and volume specification for reporting interstitial brachytherapy, International Commission on Radiation Units and Measurements, ICRU, Bethesda, Maryland, USA; 1997.
33. M. Ismail, and L.G. Gomella Ultrasound for prostate imaging and biopsy Curr Opin Urol 11 2001 471 477
34. P.A. Johnstone, R. Riffenburgh, and E.L. Saunders Grading inaccuracies in diagnostic biopsies revealing prostatic adenocarcinoma: implications for definitive radiation therapy Int J Radiat Oncol Biol Phys 32 1995 479 482
35. C.R. King, T.A. DiPetrillo, and D.E. Waser Optimal radiotherapy for prostate cancer: predictions for conventional external beam IMRT, and brachytherapy from radiobiologic models Int J Radiat Oncol Biol Phys 46 2000 165 172
36. C.R. King, and J. Fowler A simple analytic derivation suggests that prostate cancer alpha/beta ratio is low Int J Radiat Oncol Biol Phys 51 2001 213 214
37. V.R. Kini, G.K. Edmundson, F.A. Vicini, D.A. Jaffray, G. Gustafson, and A.A. Martinez Use of three-dimensional radiation therapy planning tools and intraoperative ultrasound to evaluate high dose rate prostate brachytherapy implants Int J Radiat Oncol Biol Phys 43 1999 571 578
38. G. Kovacs, R. Galalae, and B. Wirth Optimisation of interstitial brachytherapy by a new implant technique in the treatment of prostate cancer (ger) Strahlenther Onkol 171 1995 685 688
39. G. Kovács, R. Galalae, and T. Loch Treatment outcome following high dose rate brachytherapy and external beam radiation in localized prostate cancer - the Kiel experience (ger.) S.L. Roth R. Ackermann W.-J. Bock H.E. Gabbert U. Ganzer U. Göbel D. Häussinger R. Haas H.-D. Röher K.W. Schulte Klinische Onkologie 2000/'01 2000 Tumorzentrum Düsseldorf e.V Düsseldorf 343 347
40. C.A. Lawton, K. Winter, and K. Murray Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavourable prognosis carcinoma of the prostate Int J Radiat Oncol Biol Phys 49 2001 937 946
41. A.K. Lee, S. Schultz, A.A. Renshaw, J.P. Richie, and A.V. D'Amico Optimizing patient selection for prostate monotherapy Int J Radiat Oncol Biol Phys 49 2001 673 677
42. F. Lee, D.B. Siders, and S.T. Torp-Pedersen Prostate cancer: transrectal ultrasound and pathology comparison: a preliminary study of outer gland (peripheral and central zones) and inner gland (transition zone) cancer Cancer 67 1987 1132 1136
43. W.R. Lee, C. Hall, R.P. McQuellon, L.D. Case, and D.L. McCullogh A prospective quality-of-life study in men with clinically localized prostate carcinoma treated with radical prostatectomy, external beam radiotherapy, or interstitial brachytherapy Int J Radiat Oncol Biol Phys 51 2001 614 623
44. W. Lilleby, S.D. Fossa, H.R. Waehre, and D.R. Olsen Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy Int J Radiat Oncol Biol Phys 43 1999 735 743
45. T. Loch, H. Bertermann, and M. Stöckle Technische und anatomische Grundlagen des transrektalen Ultraschalls (TRUS) der Prostata Urologe B 40 2000 475 483
46. T. Loch, G. Kovacs, and N. Nürnberg High dose rate brachytherapy (HDR-BT) for local recurrence after radical prostatectomy: a new treatment modality Radiother Oncol 51 1999 S10
47. T. Loch, J.E. McNeal, and T.A. Stamey Interpretation of bilateral positive biopsies in prostate cancer J Urol 154 1995 1078 1083
48. S.A. Loening, and J.W. Tuner Use of percutaneous transperineal Au-198 seeds to treat recurrent prostate adenocarcinoma after failure of definitive radiotherapy Prostate 23 1993 283 290
49. A.A. Martinez, J. Gonzalez, and J. Stromberg Conformal prostate brachytherapy: initial experience of a phase I/II dose-escalating trial Int J Radiat Oncol Biol Phys 33 1995 1019 1027
50. A.A. Martinez, L.L. Kestin, and J.S. Stromberg Internim report of image guided conformal high dose rate brachytherapy for patients with unfavourable prostate cancer: the William Beaumont phase II dose escalating trial Int J Radiat Oncol Biol Phys 47 2000 343 352
51. A.A. Martinez, I. Pataki, and G. Edmundson Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favourable stage prostate cancer: a feasibility report Int J Radiat Oncol Biol Phys 49 2001 61 69
52. A.A. Martinez, J.A. Stitt, and B.L. Speiser Conformal interstitial HDR brachytherapy C.A. Perez L.W. Brady Principles and practice of radiation oncology 3rd ed 1998 Lippincott-Raven Philadelphia 576 582
53. T.P. Mate, J.E. Gottesman, J. Hatton, M. Gribble, and L. van Hollebeke High dose rate afterloading 192 iridium prostate brachytherapy: feasibility report Int J Radiat Oncol Biol Phys 41 1998 525 533
54. G.S. Merrick, K. Wallner, W.M. Buttler, R.W. Galbreath, J.H. Lief, and M.L. Benson A comparison of radiation dose to the bulb of the penis in men with and without prostate brachytherapy - induced erectile dysfunction Int J Radiat Oncol Biol Phys 50 2001 597 604
55. M.M. Morris, K.C. Dallow, and A.L. Zietmann Adjuvant and salvage irradiation following radical prostatectomy for prostate cancer Int J Radiat Oncol Biol Phys 38 1997 731 736
56. S. Nag, D. Beyer, and J. Friedland American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer Int J Radiat Oncol Biol Phys 44 1999 789 799
57. P. Niehoff, T. Loch, and R. Galalae HDR brachytherapy treatment for local recurrence after radical prostatectomy: first results and experiences Radiother Oncol 55 2000 44
58. A.W. Partin, M.W. Kattan, and E.N. Subong Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update JAMA 277 1997 1445 1451
59. H. Ragde, A.A. Elgamal, and P.B. Snow Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma Cancer 83 1998 989 1001
60. M. Riccabona, J. Hammer, and A. Schorn Percutaneous, perineal, ultrasound-controlled implantation of 125iodine in prostatic cancer: technics, report of initial experiences and comparison with the retropubic method of implantation Urologe [A] 26 1987 15 21
61. P. Rubin, L.S. Constine, and L.F. Fajardo Late effects consensus conference: RTOG/EORTC Radiother Oncol 35 1995 5 7
62. M. Sanchez-Chapado, J.C. Angulo, and C. Ibarburen Comparison of digital rectal examination, transrectal ultrasonography, and multicoil magnetic resonance imaging for preoperative evaluation of prostate cancer Eur Urol 32 1997 140 149
63. P. Simina, Ch.J. Schneider, and J. Fowler The optimal fraction size in high dose rate brachytherapy: dependency on tissue repair kinetics and low-dose rate Int J Radiat Oncol Biol Phys 52 2002 844 849
64. D.M. Steinberg, J. Sauvageot, and S. Piantadosi Correlation of needle biopsy and radical prostatectomy Gleason grade in academic and community settings Am J Surg Pathol 21 1997 566 576
65. J.S. Stromberg, A. Martinez, and R. Benson Improved local control and survival for surgically staged patients with locally advanced prostate cancer treated with up-front low-dose rate iridium-192 prostate implantation and external beam irradiation Int J Radiat Oncol Biol Phys 28 1994 171 177
66. J.S. Stromberg, A. Martinez, and E.M. Horwitz Conformal high dose rate iridium-192 boost brachytherapy in locally advanced prostate cancer: superior prostate specific antigen response compared with external beam treatment Cancer J Sci Am 3 1997 346 352
67. B.S. Teh, B.M. Berner, and L.S. Carpenter Permanent gold-198 implant for locally recurrent adenocarcinoma of the prostate after failing initial radiotherapy J Brachyther Int 14 1998 233
68. B.R. Thomadsen, P.V. Houdek, G. Edmundson, R. van der Laarse, I.K.K. Kolkmann-Deurloo, and A.G. Visser Treatment planning and optimisation S. Nag High dose rate (HDR) brachytherapy. A textbook 1994 Future Publishing Company 19 145
69. F.A. Vicinci, R.K. Vijay, G. Edmundson, G.S. Gustavson, J. Stromberg, and A.A. Martinez A comprehensive review of prostate cancer brachytherapy: defining an optimal technique Int J Radiat Oncol Biol Phys 44 1999 483 491
70. A.G. Visser, G.J.M.J. van der Aardweg, and P.C. Levendag Pulsed dose rate and fractionated high dose rate brachytherapy: choice of brachytherapy schedules to replace low dose rate treatments Int J Radiat Oncol Biol Phys 34 1996 497 505
71. K. Wallner, W. Ellis, K. Russsel, W. Cavanagh, and J. Blasko Use of TRUS to predict pubic arch interference of prostate brachytherapy Int J Radiat Oncol Biol Phys 43 1999 583 585
72. J.W. Yarbro, D.L. Page, L.P. Fielding, E.E. Partridge, and G.P. Murphy American Joint Committee on Cancer Prognostic Factors Consensus Conference Cancer 86 1999 2436 2446
73. Y. Yoshioka, T. Nose, and T. Yoshida High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: treatment description and preliminary results of a phase I/II clinical trial Int J Radiat Oncol Biol Phys 48 2000 675 681
74. G.K. Zagars, A. Pollack, and A.C. von Eschenbach Prostate cancer and radiation therapy: the message covered by serum prostate specific antigen Int J Radiat Oncol Biol Phys 33 1995 23 25